Another recent study illustrated that the suppression of DNA excision repair protein ERCC-6, also known as cockayne syndrome B (CSB), a pleiotropic protein and essential DNA repair factor, could hamper the proliferative, clonogenic, and invasive capabilities in NB, making CSB ablation a promising anticancer strategy for NB therapy [19]. This evidence concerns the gene ERCC6 and Down syndrome.